Natixis Investment Managers International cut its stake in shares of Chemed Co. (NYSE:CHE – Free Report) by 26.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 30,080 shares of the company’s stock after selling 10,890 shares during the period. Natixis Investment […]
Natixis Investment Managers International reduced its stake in Roper Technologies, Inc. (NYSE:ROP – Free Report) by 0.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,321 shares of the industrial products company’s stock after selling 56 shares during the quarter. Natixis Investment […]
Natixis Investment Managers International boosted its position in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 23.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 5,755 shares of the medical research company’s stock after buying an additional 1,100 shares during the […]
Natixis Investment Managers International grew its holdings in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 0.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 116,278 shares of the company’s stock after buying an additional 44 shares […]
Natixis Investment Managers International lifted its position in VeriSign, Inc. (NASDAQ:VRSN – Free Report) by 7.0% in the 4th quarter, Holdings Channel.com reports. The fund owned 144,125 shares of the information services provider’s stock after acquiring an additional 9,455 shares during the period. VeriSign comprises 2.1% of Natixis Investment Managers International’s investment portfolio, making the […]